ROIV News and Press, Roivant Sciences Ltd. From 10/13/23

2023-10-13 08:10:01 ET More on Roivant Sciences Skin In The Game: Behind Roivant's Significant Rise Immunovant to raise $450M from public offering and private placement Immunovant stock rallies for second day, fueled by public offering, drug data For further ...

BOSTON, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Covant Therapeutics, an innovative covalent drug discovery company, is pleased to announce the appointment of Vincent Hennemand as Chief Executive Officer (CEO). Vincent Hennemand is a seasoned executive with a distinguished career in the pharmaceutic...

2023-10-09 13:48:11 ET The FDA's decision to reject a label expansion for Alnylam’s ( NASDAQ: ALNY ) amyloidosis therapy patisiran on Monday pressured shares of Arbutus Biopharma ( NASDAQ: ABUS ), which has out-licensed the product to the RNAi therapeutics company. ...

2023-10-03 12:23:17 ET More on Roivant Sciences Skin In The Game: Behind Roivant's Significant Rise Roivant Sciences Ltd. (ROIV) Q1 2023 Earnings Call Transcript Roivant Sciences Ltd. 2023 Q1 - Results - Earnings Call Presentation Immunovant to raise $450M fr...

2023-10-01 08:30:00 ET Despite the infamous market crashes in October of 1907, 1929, and 1987, October is actually one of the better months for stocks from a historical perspective. In fact, stocks tend to perk up at the start of the fourth quarter, making it one of the better-performing pe...

2023-09-29 17:45:26 ET More on Roivant Sciences Skin In The Game: Behind Roivant's Significant Rise Roivant Sciences Ltd. (ROIV) Q1 2023 Earnings Call Transcript Roivant Sciences Ltd. 2023 Q1 - Results - Earnings Call Presentation Immunovant to raise $450M fr...

2023-09-28 07:31:31 ET More on Immunovant, Roivant, etc. Immunovant: Immune Boost, From Clinical Trials To An Aggressive Bullish Stock Immunovant: Data Sizzles, But The Steak Isn't Done Yet (Rating Upgrade) Skin In The Game: Behind Roivant's Significant Rise ...

2023-09-27 12:21:54 ET Shares of Immunovant (NASDAQ: IMVT) , an autoimmune specialist and subsidiary of Roivant Sciences (NASDAQ: ROIV) , are showing no signs of cooling off after nearly doubling in value on Tuesday. Specifically, the drugmaker's shares were up by another 5....

2023-09-27 10:29:47 ET More on Immunovant Immunovant: Immune Boost, From Clinical Trials To An Aggressive Bullish Stock Immunovant: Data Sizzles, But The Steak Isn't Done Yet (Rating Upgrade) Immunovant, Inc. 2023 Q2 - Results - Earnings Call Presentation Imm...

2023-09-27 09:55:35 ET DENVER, Colo., Sept 27, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ShiftPixy Inc (NASDAQ: PIXY), Galecto Inc (NASDAQ: GLTO), Cardiff Oncology Inc (NASDAQ: CRDF), American Strat...